Communiqués BIOLASE, Inc.

Actions

BIOL

US0909117022

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/05/2024			Varia. 5j.	Varia. 1 janv.
0,1708 ^USD	-11,96 %		+3,14 %	-84,78 %

14/05	Wall Street s'apprête à ouvrir sur une note stable mardi, alors que l'indicateur principal de l'inflation a augmenté plus que prévu	MT
14/05	Les plus mauvais élèves du prémarché	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BIOLASE : Failure to Satisfy Listing Rule - Form 8-K	17/05	PU
Biolase: Q1 Earnings Snapshot	13/05	AQ
Biolase: Q4 Earnings Snapshot	21/03	AQ
BIOLASE TO REPORT FOURTH QUARTER AND FULL YEAR 2023 RESULTS ON MARCH 21, 2024	15/03	AQ
BIOLASE LAUNCHES STATE-OF-THE-ART ALL-TISSUE LASER SYSTEM TO ACCELERATE ADOPTION OF LASERS IN DENTISTRY	23/02	AQ
BIOLASE ANNOUNCES FIRST QUARTER 2024 WEBINAR SERIES 'LETS TALK DENTAL'	21/02	AQ
BIOLASE, INC. GRANTED EXTENSION BY NASDAQ TO REGAIN COMPLIANCE WITH THE STOCKHOLDERS EQUITY CONTINUED LISTING REQUIREMENT	15/02	AQ
BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024	30/01	AQ
BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	06/12	PR
Biolase: Q3 Earnings Snapshot	09/11	AQ
BIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIES	09/11	PR
LANDMARK STUDY PERFORMED BY THE INDEPENDENT MCGUIRE INSTITUTE CONFIRMS POSITIVE 12 MONTH CLINICAL OUTCOMES FOR BIOLASE REPAIR PERIO PROTOCOL	09/11	AQ
BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants	18/09/23	PR
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants	14/09/23	PR
Biolase: Q2 Earnings Snapshot	10/08/23	AQ
Four Dynamic Stocks and their Latest Moves (CAVR, IDEX, NAVB, BIOL)	13/07/23	AQ
BIOLASE, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	13/06/23	AQ
BIOLASE ANNOUNCES DISTRIBUTION OF SERIES I PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK	05/06/23	PR
BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants	26/05/23	PR
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants	24/05/23	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués BIOLASE, Inc.

Actions

BIOL

US0909117022

Communiqués

Filtres